4.5 Article

Cellular mechanisms underlying the impairment of macrophage efferocytosis

Journal

IMMUNOLOGY LETTERS
Volume 254, Issue -, Pages 41-53

Publisher

ELSEVIER
DOI: 10.1016/j.imlet.2023.02.001

Keywords

Apoptosis; Efferocytosis; Inflammation resolution; Macrophage; Neutrophil; Phagocytosis

Categories

Ask authors/readers for more resources

Phagocytosis and clearance of dying cells by macrophages, known as efferocytosis, play crucial roles in maintaining homeostasis and promoting tissue repair. Defects in efferocytosis are implicated in various inflammatory and autoimmune diseases. This review highlights the signaling and metabolic processes of macrophage efferocytosis, its importance in tissue homeostasis and repair, and the mechanisms underlying efferocytotic abnormalities in disease or injury conditions. Potential molecular targets for enhanced efferocytosis in animal models of disease are also discussed.
The phagocytosis and clearance of dying cells by macrophages, a process termed efferocytosis, is essential for both maintaining homeostasis and promoting tissue repair after infection or sterile injury. If not removed in a timely manner, uncleared cells can undergo secondary necrosis, and necrotic cells lose membrane integrity, release toxic intracellular components, and potentially induce inflammation or autoimmune diseases. Efferocytosis also initiates the repair process by producing a wide range of pro-reparative factors. Accumulating evidence has revealed that macrophage efferocytosis defects are involved in the development and progression of a variety of inflammatory and autoimmune diseases. The underlying mechanisms of efferocytosis impairment are complex, disease-dependent, and incompletely understood. In this review, we will first summarize the current knowledge about the normal signaling and metabolic processes of macrophage efferocytosis and its importance in maintaining tissue homeostasis and repair. We then will focus on analyzing the molecular and cellular mechanisms underlying efferocytotic abnormality (impairment) in disease or injury conditions. Next, we will discuss the potential molecular targets for enhanced efferocytosis in animal models of disease. To provide a balanced view, we will also discuss some deleterious effects of efferocytosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available